Hearing Wrap Up: Oversight Committee Exposes How PBMs Undermine Patient Health and Increase Drug Costs
July 24, 2024
July 24, 2024
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, the House Committee on Oversight and Accountability held a hearing titled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability." At the hearing, Republicans and Democrats pressed Pharmacy Benefit Manager (PBM) chief executives on their role in ri . . .
Today, the House Committee on Oversight and Accountability held a hearing titled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability." At the hearing, Republicans and Democrats pressed Pharmacy Benefit Manager (PBM) chief executives on their role in ri . . .